Adalimumab (humira (R)) is effective in treating patients with advanced stage of ankylosing spondylitis (AS)

dc.contributor.author	Rudwaleit, Martin
dc.contributor.author	Torre Alonso, Juan Carlos
dc.contributor.author	Spieler, Wolfgang
dc.contributor.author	Wong, Robert L.
dc.contributor.author	Kron, Martina
dc.contributor.author	Kary, Sonja
dc.contributor.author	Kupper, Hartmut
dc.date.accessioned	2013-01-30T10:14:34Z
dc.date.available	2013-01-30T10:14:34Z
dc.date.issued	2008
dc.identifier.citation	Clinical and Experimental Rheumatology, 26(4), p. 743-744 (2008)	spa
dc.identifier.issn	0392-856X
dc.identifier.uri	http://www.clinexprheumatol.org/article.asp?a=3481
dc.identifier.uri	http://hdl.handle.net/10651/9631
dc.format.extent	p. 743-744	spa
dc.language.iso	eng
dc.relation.ispartof	Clinical and Experimental Rheumatology	spa
dc.source	Scopus	spa
dc.title	Adalimumab (humira (R)) is effective in treating patients with advanced stage of ankylosing spondylitis (AS)	spa
dc.type	journal article
dc.identifier.local	302	spa

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.